US Stock MarketDetailed Quotes

BRTH Breathe BioMedical

Watchlist
  • 0.000
  • 0.0000.00%
Close Sep 11 09:30 ET
0Market Cap0.00P/E (TTM)

Breathe BioMedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
164.61%3.53M
75.40%8.9M
1.33M
11.41%5.07M
4.55M
Selling and administrative expenses
338.18%2.85M
101.89%6.7M
--650.6K
2.67%3.32M
--3.23M
-Selling and marketing expense
-99.27%89
-4.89%61.61K
--12.23K
-58.51%64.77K
--156.11K
-General and administrative expense
346.55%2.85M
104.02%6.64M
--638.37K
5.78%3.25M
--3.08M
Research and development costs
-9.34%571.35K
14.61%2.09M
--630.21K
13.91%1.82M
--1.6M
Depreciation amortization depletion
43.18%132.85K
47.13%383.26K
--92.79K
18.06%260.48K
--220.63K
-Depreciation and amortization
43.18%132.85K
47.13%383.26K
--92.79K
18.06%260.48K
--220.63K
Other operating expenses
35.41%-25.76K
17.18%-271.5K
---39.87K
34.29%-327.83K
---498.91K
Operating profit
-164.61%-3.53M
-75.40%-8.9M
-1.33M
-11.41%-5.07M
-4.55M
Net non-operating interest income expense
-323.87%-10.6K
-211.55%-16.15K
4.73K
19.46%14.48K
12.12K
Total other finance cost
323.87%10.6K
211.55%16.15K
---4.73K
-19.46%-14.48K
---12.12K
Other net income (expense)
18.76%203.85K
-7.82%555K
171.65K
5.27%602.07K
571.95K
Gain on sale of security
16.92%5.6K
-166.07%-4.27K
--4.79K
-53.24%6.46K
--13.82K
Other non- operating income (expenses)
18.81%198.25K
-6.10%559.27K
--166.86K
6.71%595.6K
--558.13K
Income before tax
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Income tax
0
0
0
0
0
Net income
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Net income continuous Operations
-188.25%-3.34M
-87.57%-8.36M
---1.16M
-12.28%-4.46M
---3.97M
Minority interest income
Net income attributable to the parent company
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Basic earnings per share
-188.25%-0.3056
-87.57%-0.7661
-0.106
-12.28%-0.4085
-0.3638
Diluted earnings per share
-188.25%-0.3056
-87.57%-0.7661
-0.106
-12.28%-0.4085
-0.3638
Dividend per share
Currency Unit
CAD
CAD
CAD
CAD
CAD
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 00000
Operating revenue --0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 164.61%3.53M75.40%8.9M1.33M11.41%5.07M4.55M
Selling and administrative expenses 338.18%2.85M101.89%6.7M--650.6K2.67%3.32M--3.23M
-Selling and marketing expense -99.27%89-4.89%61.61K--12.23K-58.51%64.77K--156.11K
-General and administrative expense 346.55%2.85M104.02%6.64M--638.37K5.78%3.25M--3.08M
Research and development costs -9.34%571.35K14.61%2.09M--630.21K13.91%1.82M--1.6M
Depreciation amortization depletion 43.18%132.85K47.13%383.26K--92.79K18.06%260.48K--220.63K
-Depreciation and amortization 43.18%132.85K47.13%383.26K--92.79K18.06%260.48K--220.63K
Other operating expenses 35.41%-25.76K17.18%-271.5K---39.87K34.29%-327.83K---498.91K
Operating profit -164.61%-3.53M-75.40%-8.9M-1.33M-11.41%-5.07M-4.55M
Net non-operating interest income expense -323.87%-10.6K-211.55%-16.15K4.73K19.46%14.48K12.12K
Total other finance cost 323.87%10.6K211.55%16.15K---4.73K-19.46%-14.48K---12.12K
Other net income (expense) 18.76%203.85K-7.82%555K171.65K5.27%602.07K571.95K
Gain on sale of security 16.92%5.6K-166.07%-4.27K--4.79K-53.24%6.46K--13.82K
Other non- operating income (expenses) 18.81%198.25K-6.10%559.27K--166.86K6.71%595.6K--558.13K
Income before tax -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Income tax 00000
Net income -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Net income continuous Operations -188.25%-3.34M-87.57%-8.36M---1.16M-12.28%-4.46M---3.97M
Minority interest income
Net income attributable to the parent company -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Basic earnings per share -188.25%-0.3056-87.57%-0.7661-0.106-12.28%-0.4085-0.3638
Diluted earnings per share -188.25%-0.3056-87.57%-0.7661-0.106-12.28%-0.4085-0.3638
Dividend per share
Currency Unit CADCADCADCADCAD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg